Stocks Comparison
Cresco Labs vs Usana Health Sciences: revenue, profit, margins and growth compared
Cresco Labs brought in $655.8M of revenue in fiscal 2025, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by -9.5% at Cresco Labs and +8.3% at Usana Health Sciences on the year before, so Usana Health Sciences grew faster. Cresco Labs kept -20.6% of its revenue as net profit, Usana Health Sciences 1.2%. Free cash flow was $37.8M at Cresco Labs and $8.5M at Usana Health Sciences.
Side by side, latest fiscal year
| CRLBF | USNA | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (January 3, 2026) |
| Revenue | $655.8M | $925.3M |
| Revenue growth | -9.5% | +8.3% |
| Net income | -$135.4M | $10.8M |
| Net margin | -20.6% | 1.2% |
| Free cash flow | $37.8M | $8.5M |
| Free cash flow margin | 5.8% | 0.9% |
| Earnings per share (diluted) | -$0.38 | $0.58 |
| Cash | $57.9M | $158.4M |
| Debt | $420.4M | n/a |
| Price to earnings | n/a | 25.6 |
| Market value | n/a | $273.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #185 of 742 · Health care | #158 of 742 · Health care |
Over the years
Questions about Cresco Labs and Usana Health Sciences
Which is bigger by revenue, Cresco Labs or Usana Health Sciences?
Usana Health Sciences is bigger by revenue: $925.3M in fiscal 2025, against $655.8M for Cresco Labs in fiscal 2025.
Which keeps more of its revenue as profit, Cresco Labs or Usana Health Sciences?
Cresco Labs had a net margin of -20.6% in fiscal 2025; Usana Health Sciences had 1.2% in fiscal 2025.
Which grew revenue faster, Cresco Labs or Usana Health Sciences?
In their latest fiscal years revenue changed by -9.5% at Cresco Labs and +8.3% at Usana Health Sciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.